Welcome to Capital Essence

Sign up for a FREE MEMBERSHIP to read tons of free content. Take a 30-DAY Trial Offer to access premium research and trading strategy. Check out our Investment Blog for the latest trading/investment ideas. If you want to go beyond the latest numbers, our Market Outlook will tell you why the market does what it does and what it means for the next day’s trading.
Trading Strategy – iShares Nasdaq Biotechnology ETF

  One of the more noteworthy developments in recent days has been the move in biotech stocks.  The group attracted strong buying support in recent day that saw the iShares Nasdaq Biotechnology ETF (IBB) surged more than 4 percent last week, bringing its YTD gains up to 14.4 percent while the S&P gained 8.5 percent …[read more]

Trading Strategy –  iShares Nasdaq Biotechnology ETF

  Biotech caught a bid Friday after Biogen announced positive results from a study on a drug aimed at treating early Alzheimer’s disease, its shares rose nearly 20 percent.  The iShares Nasdaq Biotechnology ETF (IBB) surged 3.8 percent, bringing its YTD gains up to nearly 9 percent, outperformed the S&P by a wide margin.  Now …[read more]

Trading Strategy – iShares Nasdaq Biotechnology ETF

  One of the more noteworthy developments in recent days has been the move in biotech.  The iShares Nasdaq Biotechnology ETF (IBB) now up about 12% from its November lows to trade at 112, near two-year nigh.  Not only is that IBB overbought following recent advance, the ETF also drawing the attention of bears.  Now …[read more]

Trading Strategy – iShares Nasdaq Biotechnology ETF

  Healthcare stocks come back into the spotlight following report that Senate Majority Leader Mitch McConnell plans to bring a last-ditch bill to repeal and replace big parts of Obamacare to a vote in the Senate next week. The iShares Nasdaq Biotechnology ETF (IBB) rose 0.85 percent to 332.75. The ETF has risen more than …[read more]

Trading Strategy – iShares NASDAQ Biotechnology Index ETF

  Short sellers should be worries that biotech is leading the market higher Wednesday. The iShares NASDAQ Biotechnology Index ETF (IBB) jumped 2.05% to 324.32. YTD, it’s up more than 22% while the S&P and the NASDAQ are up 10% and 18% respectively. Now the question is ‘whether the rally has some legs?’ Below is …[read more]

Archives